Related Experiment Video
Updated: Feb 26, 2026
Establishment of Orthotopic Patient-derived Xenograft Models for Brain Tumors using a Stereotaxic Device
Published on: May 2, 2025
Fingering the Correct Culprit: NonRANdom Target Selection for Therapy of Neuroblastoma
Vijay Ramaswamy1, Michael D Taylor2
1Division of Haematology/Oncology, Hospital for Sick Children, Toronto, ON, Canada.
Abstract:
Despite major advances in the genomics of neuroblastoma, high-risk patients still have considerable morbidity and mortality even with aggressive chemotherapy. In a recent article published in Cancer Cell, Schnepp et al. used an integrated genomic approach to identify the Ras-related nuclear protein (RAN) pathway as being integral in neuroblastoma pathogenesis and provided compelling validation for a role of the LIN28B-RAN-Aurora Kinase A (AURKA) pathway in neuroblastoma. This opens the door to less-toxic and more-effective therapy for high-risk neuroblastoma in the near future.
Insights
Researchers identified the LIN28B-RAN-Aurora Kinase A pathway as crucial in high-risk neuroblastoma. This discovery offers hope for developing more effective and less toxic treatments for this challenging childhood cancer.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Neuroblastoma, a common childhood cancer, presents significant treatment challenges, particularly for high-risk cases.
- Despite genomic advances, high-risk neuroblastoma patients face substantial morbidity and mortality with current therapies.
Purpose of the Study:
- To investigate the genomic underpinnings of neuroblastoma pathogenesis.
- To identify novel therapeutic targets for high-risk neuroblastoma.
Main Methods:
- Utilized an integrated genomic approach to analyze neuroblastoma samples.
- Validated the role of specific molecular pathways in neuroblastoma development.
Main Results:
- Identified the Ras-related nuclear protein (RAN) pathway as integral to neuroblastoma pathogenesis.
- Provided compelling evidence for the LIN28B-RAN-Aurora Kinase A (AURKA) pathway's role in neuroblastoma.
Conclusions:
- The LIN28B-RAN-AURKA pathway represents a critical driver in high-risk neuroblastoma.
- This finding paves the way for developing novel, less-toxic therapeutic strategies for neuroblastoma patients.
